Another JAK Inhibitor Shows Efficacy for Atopic Dermatitis Another JAK Inhibitor Shows Efficacy for Atopic Dermatitis

A novel JAK inhibitor being evaluated for a broad array of inflammatory diseases was associated with efficacy and safety for treating atopic dermatitis in a pivotal multinational phase 3 trial.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news